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A B S T R A C T
It is well accepted that estrogens, the primary female sex hormones, play a key role in modulating different
aspects of the immune response. Moreover, estrogens have been linked with the sexual dimorphism observed in
some immune disorders, such as chronic inflammatory and autoimmune diseases. Nevertheless, their effects are
often controversial and depend on several factors, such as the pool of estrogen receptors (ERs) involved in the
response. Their classical mode of action is through nuclear ERs, which act as transcription factors, promoting the
regulation of target genes. However, it has long been noted that some of the estrogen-mediated effects cannot be
explained by these classical receptors, since they are rapid and mediated by non-genomic signaling pathways.
Hence, the interest in membrane ERs, especially in G protein-coupled estrogen receptor 1 (GPER1), has grown in
recent years. Although the presence of nuclear ERs, and ER signaling, in immune cells in mammals and fish has
been well documented, information on membrane ERs is much scarcer. In this context, the present manuscript
aims to review our knowledge concerning the effect of estrogens on fish immunity, with special emphasis on
GPER1. For example, the numerous tools developed over recent years allowed us to report for the first time that
the regulation of fish granulocyte functions by estrogens through GPER1 predates the split of fish and tetrapods
more than 450 million years ago, pointing to the relevance of estrogens as modulators of the immune responses,
and the pivotal role of GPER1 in immunity.
1. Overview
It is increasingly evident that estrogens are not simply reproductive
hormones since they have numerous additional functions, among which
their immunomodulatory role stands out. This is in part due to the
presence of estrogen receptors (ERs) in immune cells, as found in both
mammals and fish. Estrogens mainly exert their effects through nuclear
ERs, but the identification of a membrane ER, the G protein-coupled
estrogen receptor 1 (GPER1), which mediates rapid and non-genomic
actions, suggests that it is worth exploring its involvement in estrogens-
mediated effects on immune response since the existing data are very
scarce, even in mammals. The physiological and pathological effects of
estrogens on the immune response, and the mechanisms involved,
should be explored since that could take importance in several contexts,
including estrogenic disruption, comparative immunology studies and
aquaculture.
2. Fish immune system
Fish occupy a key phylogenetic position in the vertebrate phyloge-
netic tree, being the first animal group that possess an adaptive immune
system. Thus, the immune system of fish is physiologically similar to
that of higher vertebrates, despite certain differences, having a less
complex adaptive immune system. Despite that, both innate and
adaptive immune systems, and their interactions, play essential roles
both in fish and mammalian immunity. Fish lack bone marrow, so, a
primary organ called head kidney acts as haematopoietic organ, which
also has an excretory function in its posterior portion. Moreover, they
have thymus and spleen as lymphoid organs. Their innate response
comprises physical barriers (epithelium and mucosa and its secretion,
mucus), cellular effectors and humoral factors (Magnadottir, 2006).
Thus, fish have mucosa-associated lymphoid tissue (MALT), which in-
cludes that associated with gut (GALT), skin (SALT), gill (GALT) and
nasopharynx tissue (NALT) (Salinas, 2015). The innate cellular re-
sponse encompasses a variety of leukocytes, including phagocytes
(monocytes/macrophages and neutrophilic granulocytes) and non-
specific cytotoxic cells. Phagocytosis, the production of reactive oxygen
intermediates (ROS) and nitric oxide (NO), cell degranulation, among
others, are mechanisms used by innate immunity to remove pathogens.
The innate immune system uses a wide spectrum of pattern recognition
receptors (PRRs), such as Toll-Like Receptors (TLR), which are able to
recognize pathogen-associated molecular patterns (PAMPs). Beside
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cellular effectors, there are several humoral effectors that act in the
innate defence, including bacterial growth inhibitors, viral replication
inhibitors, lysozyme, lectins, natural antibodies and the complement
components, among others. On the other hand, as in mammals, the fish
adaptive immune response comprises a cellular and a humoral com-
ponent. The cellular component can be divided into B-cells responsible
for antibody production, and T-cells that mediate cell-mediated im-
munity. Two cell populations equivalent to mammalian B and T lym-
phocytes have been described in fish (Mutoloki et al., 2014). Anti-
bodies, produced by these B lymphocytes, are key mediators in the
adaptive immune response. Differently from mammals, three im-
munoglobulins (Ig) have been identified in teleost: IgM, the most
common in serum; IgD (Edholm et al., 2011), whose relevance remains
to be determined; and IgT, which seems to be specialized in mucosal
immunity, and so appears to be the functional equivalent of mammalian
IgA (Danilova et al., 2005; Zhang et al., 2010). Moreover, cytokines,
whose expression of some of them is induced by PRR activation, are key
regulators of the mammalian and fish immune response where they
mediate effector phases in both innate and adaptive immunity; pro-
inflammatory cytokines such as interleukin 1β (IL-1β) and tumoral
necrosis factor α (TNF-α) stand out in this respect.
3. Estrogens and ERs
Estrogens, the primary female sex hormones, are responsible for the
development and regulation of the female reproductive system and
secondary sex characteristics, but also have important physiological
roles in males (Hess, 2003). Moreover, it is known that estrogens also
have multiple non-reproductive functions. So, it is incorrect to consider
estrogens simply as reproductive hormones, since that they act in a
physiological manner on a broad range of non-reproductive tissues such
as those of the immune, central nervous and cardiovascular systems,
and have skeletal, liver, skin and kidney functions. Estrogens occur in
three major natural forms: estrone (E1), 17β-estradiol (E2) and estriol
(E3), the most potent and prevalent being E2 on which this review
mainly focuses. Estrogens are produced in all vertebrates, including
fish, where they have an ancient evolutionary history and important
endocrine functions (Eick and Thornton, 2011). They are primarily
synthesized from cholesterol in gonadal tissue but also in extra-gonadal
sites such as adipose tissue, skin and brain, among others (Nelson and
Bulun, 2001). The synthesis and release of estrogens is regulated by the
hypothalamus-pituitary-gonadal axis. The steroidogenic pathway con-
sists of a series of steps controlled by a large number of steroidogenic
enzymes, where conversion to E2 is a key step mediated by the enzyme
cytochrome P450 aromatase. Hence, the expression of this aromatase
serves as an indication of estrogen production.
The physiological effects of estrogens are controlled via ERs, pri-
marily nuclear ERs. As steroid hormones, estrogens are able to diffuse
through the cell membrane and bind to and activate ERs, which belong
to the nuclear receptor superfamily (Evans and Bergeron, 1988) and
have a DNA binding domain and a ligand binding domain (Chawla
et al., 2001; Wahli and Martinez, 1991). These ERs can shuttle between
the cytoplasm and the nucleus and function as ligand-activated nuclear
transcription factors that bind (directly or indirectly) to cis-acting es-
trogen response elements (ERE) in the promoter regions of target genes
and enhancer regions (Deroo and Korach, 2006), representing the
classical, nuclear or genomic actions of estrogens. In mammals, two
nuclear ERs genes are encoded, ESR1 and ESR2 (ERα and ERβ, re-
spectively), which have a similar affinity for estrogens, although they
can play distinct and non-redundant (and even opposite) roles in some
context (Lewandowski et al., 2005).
Besides the genomic action of estrogens, their rapid/non-genomic/
extranuclear effects, which were identified several decades ago, could
not be explained by classical ERs signaling. The forms of ERs related
with these extranuclear actions exists as membrane sub-populations of
nuclear ERs (Pedram et al., 2006), as isoforms of these nuclear ERs (Sun
et al., 2017) or as new receptors as G protein-coupled receptors (GPCR).
In this respect, various ERα and ERβ isoforms and splicing variants
have been described (Matthews and Gustafsson, 2003). For example,
ERα36, a new variant of ERα, mediates estrogen-stimulated MAPK/ERK
activation and is located on the plasma membrane and cytoplasm (Sun
et al., 2017), while other studies indicate that this variant is pre-
dominantly localized in mitochondria of some human tissues and cells
(Yan et al., 2017). So, nowadays, accumulating evidence has demon-
strated that estrogens exert substantial effects on mitochondrial func-
tion (Simpkins et al., 2008).
Referring to G protein-coupled receptors (GPCR), it was not until
2005, when an orphan GPCR, GPR30, now officially designated GPER1
(Alexander et al., 2011), was identified as an estrogen-binding in-
tracellular membrane GPCR by two independent laboratories
(Revankar, 2005; Thomas et al., 2005). It was later shown that GPER1
is activated by E2 (Filardo et al., 2007; Filardo, 2002; Funakoshi et al.,
2006). To date, the described mechanisms related with GPER1 activa-
tion include: rapid activation of MAPKs, ERK-1 and ERK-2 activation
through the transactivation of EGFR (Filardo, 2000), PI3K signaling
activation (Revankar, 2005), intracellular calcium mobilization
(Revankar, 2005) and the activation of adenylate cyclase and sub-
sequent cAMP activation (Filardo, 2002). It is known that this increase
in cellular cAMP stimulates protein kinase A (PKA) signaling. One of the
actions of this stimulation is that cAMP binds to the regulatory subunits
of PKA, thereby promoting their dissociation from the catalytic subunits
(Dermaku-Sopjani et al., 2014). The catalytic subunits released enter
the nucleus by passive diffusion and phosphorylate the cAMP-re-
sponsive element (CRE)-binding protein (CREB) at Ser133. Phos-
phorylated CREB promotes target gene expression at promoters con-
taining CREs (Altarejos and Montminy, 2011). Most of these
mechanisms have been reviewed (Prossnitz and Barton, 2009; Prossnitz
and Maggiolini, 2009; Wang et al., 2010). Moreover, the activation of
GPER1 by G1, a GPER1 selective agonist (Bologa et al., 2006), does not
trigger ERE-mediated activation but up-regulates the proto-oncogene
CFOS by means of a non-genomic mechanism similar to E2 (Albanito
et al., 2007). The use of this specific agonist together with the avail-
ability of several mouse models of GPER1 deficiency (Prossnitz and
Hathaway, 2015), point to the involvement of GPER1 action in the
regulation of several physiological responses and its possible relation
with disease. Thus, it has been recently shown that GPER1 is involved
in numerous functions of the neuroendocrine, cerebral, immune, car-
diovascular, kidney and reproductive systems, as well as in endocrine
regulation and metabolism. Together, these studies suggest the ther-
apeutic potential of regulating GPER1 activity as a novel approach for
the treatment of all these conditions (Prossnitz and Barton, 2011). Al-
though few data are available, mRNA for GPER1 appears to be ex-
pressed extensively in most tissues according to several reports
(Mizukami, 2010; Olde and Leeb-Lundberg, 2009).
In addition, it is important to mention that although physiological
responses to estrogens are often categorized as genomic or rapid/non-
genomic, much evidence exists that these artificially defined categories
are connected (Ma and Pei, 2007; Moriarty et al., 2006). Moreover,
nuclear and membrane ERs are considered as components of a complex
mechanism in which they both cooperate pointing to the need to un-
derstand the complex mechanism involved in estrogens-mediated ef-
fects not only in reproductive tissues but in other key contexts where
estrogens are involved.
Although outside the aim of this review, mention should be made of
compounds able to induce estrogenic activity by mimicking or antag-
onizing natural estrogens, whose presence in the environment and in-
terest in them have grown significantly in recent years. These com-
pounds are considered endocrine disruptor chemicals (EDCs) since they
can interfere with hormonally-controlled processes of humans and
wildlife, resulting in adverse effects on health, growth, development
and reproduction of individuals, their progeny or populations. Some of
these compounds, called xenoestrogens, are natural estrogens (E2,
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phytoestrogens, etc.) or synthetic substances with estrogenic effects,
considered as environmental contaminants and commonly found in
detergents, surfactants, plastics, pesticides and industrial chemicals,
including pharmaceutical estrogens (such as one of the components of
contraceptive pills, 17α-ethinylestradiol, EE2) and others considered as
selective estrogen receptor modulators (SERM) and used at clinical
level. It is known that ERs isoforms respond differently to non-steroidal
estrogenic EDCs (Tohyama et al., 2016), but have similar responses to
endogenous and synthetic steroidal estrogens, pointing to the different
roles of ERs in responses to EDCs. Moreover, some environmental es-
trogens and SERMs such as tamoxifen (a known antagonist of ERs) are
able to bind to GPER1 (Pang et al., 2008; Watson et al., 2011). This
latter fact can be associated with the increase in the risk of endometrial
carcinoma observed when tamoxifen is used in breast cancer treatment
(Goldstein, 2001). Thus, the importance of estrogenic endocrine dis-
ruption by these environmental estrogens, which could affect re-
productive capacity and other functions regulated by estrogens, should
not be underestimated, and explains why such disruption has been
extensively studied in recent years.
3.1. ERs in fish
Regarding nuclear ERs, most vertebrate species from the teleost
lineage possess at least three ERs, a single ERα gene (esr1) and two ERβ
genes, ERβ1 (esr2b) and ERβ2 (esr2a), due to the whole genome du-
plication events that occurred during ancient teleost evolution. Such is
the case with gilthead seabream (Sparus aurata L.) (Pinto et al., 2006),
Atlantic croaker (Micropogonias undulatus) (Hawkins et al., 2000),
zebrafish (Danio rerio) (Menuet et al., 2002), goldfish (Carassius auratus)
(Ma et al., 2000), European sea bass (Dicentrarchus labrax) (Halm et al.,
2004), common carp (Cyprinus carpio) (Katsu et al., 2013), medaka
(Oryzias latipes) (Chakraborty et al., 2011), and European eel (Anguilla
anguilla) (Lafont et al., 2016). Moreover, a second form of esr1 (ERα2)
has been described in rainbow trout (Oncorhynchus mykiss) (Nagler
et al., 2007), Atlantic salmon (Salmon salar) (Nikoleris and Hansson,
2015) and in some cyprinid species such as Spinibarbus denticulatus (Zhu
et al., 2008) and Pengze crucian carp (Carassius auratus var. pengze,
Pcc) (Zheng et al., 2013); so that these species have four different ERs
isotypes, two ERα and two ERβ. In the gilthead seabream, an important
Mediterranean aquaculture species in which our group has carried out
numerous studies, ERα, ERβ1 and ERβ2 have been identified and seen
to be expressed in both reproductive and non-reproductive organs such
as liver, brain, heart, kidney, intestine, gills, muscle and skin (Pinto
et al., 2005).
As in mammals, the expression of GPER1 has been observed in fish,
and both estrogen affinity (evaluated by using E2) and signaling func-
tions of GPER1 are well conserved between theses distantly related
vertebrate groups (Thomas et al., 2010). In fish, GPER1 has been de-
scribed in Atlantic croaker (Pang et al., 2008), zebrafish (Liu et al.,
2009), goldfish (Mangiamele et al., 2017), gilthead seabream (Cabas
et al., 2013), common carp (Majumder et al., 2015), and orange-spotted
grouper (Epinephelus coioides) (Nagarajan et al., 2011). Interestingly,
two GPER genes, gpera and gperb, have recently been identified in the:
(i) reproductive tissues of European eel, where they have a different
tissue distribution and regulation in response to experimentally-in-
duced maturation in both sexes (Morini et al., 2017), and (ii) European
sea bass, where gpera expression is mainly restricted to brain and pi-
tuitary in both sexes while gperb has a widespread tissue distribution,
with higher expression levels in gill, kidney and head kidney (Pinto
et al., 2017). Despite the presence of GPER1 in fish, to date, this re-
ceptor has mainly been linked with oocyte maturation (Pang et al.,
2008; Pang and Thomas, 2009), brain development (Shi et al., 2013)
and embryonic heart rate (Romano et al., 2017).
3.2. Immune cells express ERs
The presence of nuclear ERs in mammalian immune cells has been
widely described, and the preponderance of esr1 gene over the esr2
gene has been described in different mammalian models, being one of
the mechanism that control the effects of E2 on the immune system
(Straub, 2007). Moreover, it has been observed that the expression of
these receptors in leukocytes is dependent on the leukocyte lineage,
stage of development, functional phenotype and tissue microenviron-
ment.
However, the expression of ERs in fish immune tissues and specific
sub-populations of leukocytes is limited, in part due to the limited
number of cell markers and cell lines available. Nonetheless, the ex-
pression of nuclear ERs in lymphoid organs and leukocytes has been
described in several fish species (for references see below in this sec-
tion). In some cases, this expression is constitutive but in others it is
inducible or regulated by estrogen levels or by immune stimulus (for
references see below in this section). Moreover, the nuclear ERs ex-
pression pattern is not identical in all the species that have been studied
and, as in mammals, the expression has been detected to differ de-
pending on cell lineage and maturation stage (for references see below
in this section). With respect to GPER1, and even though it has received
a growing attention since its identification, the data regarding its ex-
pression in immune cells are scarce, even in mammals. Thus, the ex-
pression of GPER1 has been described in macrophages and lympho-
cytes, among other mammalian immune cells (Blasko et al., 2009;
Brunsing and Prossnitz, 2011; Rettew et al., 2010; Schneider et al.,
2014). Moreover, in human, it has been described that GPER1 is ex-
pressed in haematopoietic stem cells but not in mature megakaryocytes
(Di Vito et al., 2010), in eosinophils (Tamaki et al., 2014) and neu-
trophils (Rodenas et al., 2017a). However, there are only two studies
that have shown the presence of GPER1 in fish immune cells (Cabas
et al., 2013; Szwejser et al., 2017a).
In channel catfish (Ictalurus punctatus), ERα is expressed in spleen,
blood and head-kidney, while ERβ is only expressed in spleen (Xia
et al., 2000). However, ERβ is expressed both in the spleen and in the
head kidney of common sole (Caviola et al., 2007). Moreover, in
channel catfish, a leukocyte lineage expression analysis showed that
nuclear ERα and ERβ2 are differentially expressed depending on leu-
kocyte lineage and phenotype. In addition, this same study showed that
E2 modulates the expression and functionality of the ERα subtypes
present in all leukocytes, participating in the regulation of the immune
response, and ERα expression is downregulated by immune stimuli
such as concanavalin A (ConA) and lipopolysaccharide (LPS)
(Iwanowicz et al., 2014).
A recent study carried out in carp demonstrated the expression of
nuclear ERα and ERβ, and also that of GPER1, in lymphoid tissues and
head kidney monocytes/macrophages, neutrophils and lymphocytes,
although ERβ was hardly detectable in peripheral blood leukocytes
(Szwejser et al., 2017a). Interestingly, short-term stimulation of both
monocytes/macrophages and granulocytes, with phorbol 12-myristate
13-acetate (PMA), upregulated the GPER1 expression but not that of
nuclear ERs, while long-term exposure with ConA or LPS upregulated
ERs expression, both nuclear and GPER1, in head kidney lymphocytes
(Szwejser et al., 2017a). In juvenile rainbow trout, the four nuclear ERs
transcripts described were identified in head kidney and peripheral
blood leukocytes (Shelley et al., 2013). Moreover, E2 exposure altered
their expression, demonstrating that physiologically relevant con-
centrations of E2 can modulate several immune functions in salmonids,
although these altered levels returned to normal following the recovery
period (Shelley et al., 2013). All nuclear ER forms have been identified
in thymocytes and mast cells of European sea bass (Paiola et al., 2017).
Moreover, viral infection up-regulated the expression of the three nu-
clear receptor isotypes in head kidney of zebrafish, where no modula-
tion in gper1 expression levels was described (Lopez-Munoz et al.,
2015).
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In gilthead seabream, the three nuclear ERs, ERα, ERβ1 and ERβ2
(Pinto et al., 2006), are differently expressed in head kidney cell po-
pulations (Liarte et al., 2011b). Thus, macrophages and lymphocytes
constitutively express only the ERα gene, although the macrophage
stimulation with bacterial DNA drastically up-regulated the expression
of ERα, ERβ1 and ERβ2 genes, suggesting that the immune system in-
creases its sensitivity to E2 during development of the immune response
(Liarte et al., 2011b). Interestingly, a species-specific cell type called
acidophilic granulocyte and functionally equivalent to mammalian
neutrophils (Sepulcre et al., 2002) does not express any of the three
nuclear ERs (Liarte et al., 2011b). Nevertheless, a study focused on this
key immune cell type showed that these cells are the head kidney
leukocytes with the highest expression of GPER1, although it is also
expressed in other immune tissues such as spleen (Cabas et al., 2013).
In addition, gilthead seabream peritoneal leukocytes express ERα and
GPER1, which could induced by the dietary intake of the xenoestrogen
EE2 (Gomez Gonzalez et al., 2017). Moreover, both EE2 exposure and
an immunization program by hemocyanin modulated head kidney ERα
expression (Cabas et al., 2012), while in vivo G1 exposure did not
modulate the protein levels of GPER1 in head kidney leukocytes (Cabas
et al., 2013).
On the other hand, the presence of these receptors in immune or-
gans during the early stages of development may indicate that steroid
hormones are also involved in the maturation of the fish immune
system. In addition to the presence of ERs, the constitutive expression of
genes coding for steroidogenic enzymes has also been described in fish
leukocytes, which suggests that the local production of estrogens also
has an immunoregulatory function (Szwejser et al., 2017b).
In mammals, very data have shown that some cytokines such as
IL1β can markedly modulate E2 levels by regulating key enzymes in the
estrogens production or degradation pathway (Nakamura et al., 2003).
Nevertheless, despite the few data mentioned above about the mod-
ulation of ERs by some immune stimuli such as LPS, bacterial DNA or
immunization in fish immune cells, as far we know, there are no data
about modulation of ERs expression and functions by cytokines.
4. Estrogens modulate immune response
The immunomodulatory role of estrogens is based on the presence
of ERs in immune cells, which enable estrogens to act directly. As
mentioned above, estrogens act on multiple non-reproductive systems,
including the immune system. So, in mammals, estrogens have a key
immunomodulatory role, regulating different aspects of the immune
response (Straub, 2007), including haematopoiesis, differentiation,
lymphocyte activation, cell polarization and cytokine production. So,
estrogens have been linked with the sexual dimorphism observed in
some immune disorders, such as chronic inflammatory and auto-
immune diseases (Gilliver, 2010; González et al., 2010; Khan and Ansar
Ahmed, 2015). Nevertheless, the estrogens-mediated effects on the
immune response have also been described as complex and con-
troversial, and they can vary with factors such as target cells type and
their activation stage, physiological condition of the organism, estrogen
concentration or the pool of ERs involved, among others (Straub, 2007).
Due to the complexity of the immunoregulatory actions of estrogens, it
is generally described that low levels of E2 will stimulate the immune
response, while high E2 levels appear to be immunosuppressive (Straub,
2007). Therefore, it is of huge interest to know the physiological and
pathological effects and mechanisms of estrogens in the immune
system.
4.1. Immunomodulatory role of estrogens in fish immunity
As shall be described below, there is evidence that supports the idea
that estrogens also modulate fish immune response, although the in-
formation is more limited compared to that available for mammals.
Moreover, accumulating data suggests that estrogenic EDCs may exert
adverse effects on aquatic organisms by modulating immune compe-
tence. For this reason, fish have even been proposed as sentinel or-
ganisms to detect estrogenic contamination and the modulation of their
immune response acting as marker of such estrogenic disruption
(Casanova-Nakayama et al., 2011). In a recent study, it was demon-
strated that estrogens are able to modulate miRNAs, leading to mod-
ulation of their immune functioning, and opening the possibility of new
functional genome research on the teleost immune system and of
identifying novel molecule biomarkers for estrogenic pollution (Burgos-
Aceves et al., 2016, 2018). The study of estrogen-mediated effects and
its mechanisms on fish immunity has implications for different contexts,
such as: comparative immunology, evolutionary studies, endocrine
disruption (suggesting environmental actions), aquaculture activity
(anticipating and taking action), biomedicine (suggesting therapeutic
targets in immune disorders where estrogens are involved), among
others.
So, it is clear that a potent immune-endocrine interaction exists,
which, in fish, it has an additional anatomical platform since the head
kidney fulfils immune and endocrine functions. Nevertheless, as occurs
in mammals, the existing data in fish are sometimes controversial and,
in most cases, the mechanism that underlies these effects is poorly
understood or has been little studied, perhaps because the tools avail-
able are limited. Moreover, the observed effects of estrogens on the fish
immune response are in many cases species-specific and, as in mam-
mals, depend on the concentration used and/or the time of exposure. In
addition, in most studies on fish, information on whether E2 con-
centrations used are physiological or not (according to the species-
specific etrogen levels), is absent.
So, estrogens are able to modulate fish innate immunity, affecting a
wide range of immune parameters or activities ranging from respiratory
burst (reactive oxygen species, ROS, and NO production), lysozyme
activity, phagocytosis, bactericidal activity to the complement (for re-
ferences see below in this section). Moreover, they can affect aspects of
fish adaptive immunity such as lymphocyte proliferation and activity,
immunoglobulin levels and the development and maturation of lym-
phoid and myeloid cells (for references see below in this section). As
evidence of this immunomodulatory role of estrogens in fish, season-
dependent changes in the immune status have been seen to correlate
with changes in the levels of the circulating sex hormones in numerous
species (Szwejser et al., 2017c).
4.1.1. Effects on fish innate immune response
As regards to the influence of E2 on ROS production, a key innate
immune response, the data published indicate that E2 exposure has
different effects. A stimulatory effect has been described: (i) in carp
leukocytes with a short period of E2-incubation (Szwejser et al., 2017a),
(ii) in channel catfish adherent kidney leukocytes at lower doses of E2
(Iwanowicz et al., 2014) and (iii) in blood leukocytes of Japanese sea
bass (Thilagam et al., 2009). A suppressive effect has been observed
following: (i) intraperitoneal injection of E2 in carp macrophages
(Watanuki et al., 2002) and (ii) by in vitro long term E2 treatment in
gilthead seabream head kidney leukocytes (Liarte et al., 2011b) and
granulocytes (Chaves-Pozo et al., 2003). A non-modulating effect has
been observed with: (i) short term treatment of E2 in gilthead seabream
head kidney leukocytes (Liarte et al., 2011b), (ii) E2 treatment in carp
head kidney macrophages (Yamaguchi et al., 2001) and (iii) by in vivo
E2 exposure in rainbow trout head kidney leukocytes (Shelley et al.,
2013).
With respect to the phagocytic activity, a consistent inhibitory effect
has been described in: (i) carp head kidney macrophages after E2 ex-
posure in vitro (Yamaguchi et al., 2001) and intraperitoneal injections
(Watanuki et al., 2002); (ii) tilapia leukocytes with high doses of E2
(Oreochromis niloticus x O. aureus) (Law et al., 2001); (iii) sea bass head
kidney leukocyte after a chronic exposure to E2 (Seemann et al., 2016);
(iv) goldfish kidney macrophages (Wang and Belosevic, 1994); and (v)
gilthead seabream head kidney leukocytes after short term treatments
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with high concentrations of E2 (Liarte et al., 2011b). Nevertheless, in
some cases a non-modulating effect has been observed, for example
after in vivo E2 exposure in rainbow trout head kidney leukocytes
(Shelley et al., 2013).
A dual effect, depending on concentration, has been observed in the
bactericidal activity of E2-treated channel catfish adherent kidney leu-
kocytes, where low physiological concentrations significantly enhanced
this activity, while pharmacological concentrations significantly de-
creased it (Iwanowicz et al., 2014).
In gilthead seabream, the complement activity is also modulated by
estrogens. Accordingly, E2 enhanced complement activity after a short
time of incubation period, although it decreased later (Cuesta et al.,
2007). Moreover, the complement gene expression pattern was modu-
lated by in vivo administration of E2 after bacterial infection in rainbow
trout (Wenger et al., 2011).
The quintessential effect of estrogens in immunity is modulation of
cytokine production which they achieve by regulating the key nuclear
transcription factor NF-κB (Ghisletti et al., 2005). Accordingly, nu-
merous authors have shown that E2 exposure affects the cytokine ex-
pression profile: (i) in sea bass, E2 modulates the fine control of the
cytokine network, including IL1β and TNFα, tending to down-regulate
the expression levels (Seemann et al., 2013); (ii) strongly suppresses
TNFα expression in rainbow trout head kidney (Wenger et al., 2014);
(iii) orchestrates profound alterations in the expression profile of gilt-
head seabream head kidney macrophages, especially those from im-
mune-related processes and pathways (Liarte et al., 2011a); and (iv)
produces a significant inhibition of the IL-1β accumulation resulting
from several immune stimuli in gilthead seabream head kidney gran-
ulocytes (Chaves-Pozo et al., 2003). The effects of estrogens on cyto-
kines production will have implications on innate and adaptive immune
response since these cytokines are key modulators of both responses.
4.1.2. Effects on fish adaptive immune response
As it mentioned above, adaptive immunity is also a target for es-
trogenic effects. Thus, E2 exposure is able to modulate IgM levels. For
example, it can promote a decrease in the plasma IgM levels in infected
gilthead seabream (Cuesta et al., 2007) or in the plasma and mucosal
IgM levels in rainbow trout, in which it correlates with a reduction in
the number of IgM producing cells (Hou et al., 1999). Conversely, in
Japanese sea bass, sublethal E2 exposure promotes a significant increase
of immunoglobulin levels (Thilagam et al., 2009), while no modulation
by E2 was observed in IgM secretion from carp leukocytes (Saha et al.,
2004). On the other hand, E2 exposure leads to the involution of the
thymus and significantly modifies T-cell development (Seemann et al.,
2015). Thus, in nile tilapia, E2 regulated the expression of Foxp3, a
crucial transcription factor for the development and function of reg-
ulatory T cells, in the intestine and kidney but not in the spleen (Wei
et al., 2013). In addition, it has been described that the proliferative
capacity of immune cells is negatively impaired by E2 exposure. So, in
channel catfish, pre-treatment with E2 prior to mitogen stimulation led
to a significant decrease in mitogen-induced proliferation of peripheral
blood leukocytes (Iwanowicz et al., 2014), reduced the ability of
goldfish lymphocytes to proliferate (Wang and Belosevic, 1994) and
suppressed the leukocyte proliferation rate in rainbow trout, although
the effect varied with exposure time (Shelley et al., 2013).
Reflecting these alterations in immune parameters, in many cases an
altered susceptibility to pathogen has been observed, as in rainbow
trout infected with Yersinia ruckeri (Wenger et al., 2011) or in goldfish
infected by trypanosomes (Wang and Belosevic, 1994), where the E2-
treated fish had lower survival rates compared to control ones. More-
over, an increased susceptibility to viral infection was observed in adult
wild type zebrafish exposed to E2 and in ESR2b mutant adults (Lopez-
Munoz et al., 2015), while no differences were observed upon bacterial
infection. Finally, it has been suggested that estrogen exposure could
alter the capacity of fish to respond to infection during ontogeny since
this kind of exposure may promotes long-lasting effects on the humoral
adaptive immune response in gilthead seabream (Rodenas et al., 2015).
5. Relevance of GPER1 in immunity
The specific mechanisms through which the described estrogens-
effects are mediated are sometimes not well understood. In some cases,
the use of specific nuclear ERs antagonist and their capacity to, partially
or completely, reverse these effects, allowed the signaling pathway
involved to be suggested. Nevertheless, whether GPER1 signaling is
involved in all these estrogen-mediated effects is still unclear and has
little been studied, even in mammals.
So far, in mammals, it has been described that GPER1 is involved in
estrogen-induced thymic atrophy (Wang et al., 2008) and the impaired
production of T cells in the thymus (Isensee et al., 2009). Moreover, in
the context of autoimmune diseases, GPER1 knockout mice showed
impaired estrogen-mediated protection (Wang et al., 2009), whereas its
activation had a beneficial role in multiple sclerosis (Blasko et al.,
2009). In addition, GPER1 activation promotes a suppressive phenotype
in CD4 regulatory T cells (Brunsing et al., 2013), induces IL-10 in Th17
effector populations (Brunsing and Prossnitz, 2011), and decreases the
expression of TLR4 in murine macrophages, limiting the sensitivity of
these cells to LPS (Rettew et al., 2010). Finally, it has been described
that GPER1 is able to regulates the life span and activation towards a
pro-inflammatory phenotype of human neutrophils through several
signaling pathways (Rodenas et al., 2017a) and this novel receptor has
recently been associated with inflammatory diseases such as irritable
bowel syndrome (Jacenik et al., 2017).
In some studies, the use of G15, an antagonist of GPER1 (Dennis
et al., 2009), has also allowed to confirm that these effects are mediated
via GPER1. So, for example, it was observed that G15 antagonized the
immunomodulatory effects of G1 in treated macrophages, confirming
that GPER1 mediates immunomodulation and neuroprotection in a
mouse model of Parkinson's disease (Cote et al., 2015). Nevertheless, a
new GPER1 antagonist, G36, has been identified in order to enhance the
antagonist selectivity (Dennis et al., 2011).
In fish, the few existing data have also shown that GPER1 is in-
volved in some immune processes; furthermore, some of these results
are shown for the first time in vertebrates. So, it has been described that
GPER1 signaling is involved in the E2-induced increase of ROS pro-
duction in carp macrophages (Szwejser et al., 2017a). Moreover, it has
been demonstrated that GPER1 activation regulates the functions and
gene expression pattern of gilthead seabream acidophilic granulocytes,
cells equivalent to mammalian neutrophils, inducing an anti-in-
flammatory phenotype through a GPER/cAMP/PKA/CREB signaling
pathway (Cabas et al., 2013). Finally and for the first time in verte-
brates, it has recently been shown that GPER1 activation induced the
production of polyreactive natural antibodies (Rodenas et al., 2017b).
All together, these data have shown mainly an immunosuppressive role
for GPER1.
The knowledge that fish granulocyte functions are regulated by
estrogens through GPER1 indicates that it is an evolutionary conserved
trait and it predates the split of fish and tetrapods more than 450
million years ago. Nevertheless, the recent data regarding to GPER1
activation in bony fish granulocytes vs. human neutrophils have shown
to be opposite in some aspect, at least in these key cells, promoting an
anti- or pro-inflammatory phenotype, respectively. Therefore, while
GPER1 activation by G1 induces expression of anti-inflammatory genes
such as il10 or ptgs2 and hardly modulates ROS production in bony fish
granulocytes, GPER1 activation promotes the induction of pro-in-
flammatory genes such as IL1B and CXCL8 and induces ROS production
levels in human neutrophils (Fig. 1). Nevertheless, here it should be
mentioned that GPER1 activation in carp macrophages increase ROS
production (Szwejser et al., 2017a). Therefore, the species-specific ef-
fects probably depend on the time of treatment, the cell source, the cell
type as well as the status of activation (Szwejser et al., 2017a). More-
over, it should be taken into account that the G1 concentration
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necessary to activate GPER1 might not be the same in these different
animal groups. On the other hand, as it has been reviewed by other
authors, the subcellular localization of GPER1 is a controversial aspect
(Langer et al., 2010). In the mentioned study which focuses on fish
granulocytes (Cabas et al., 2013), it has been described an intracellular
membrane localization of GPER1 since the GPER1 staining was only
detected by using intracellular staining procedure, but not by extra-
cellular staining one. Moreover, the evidence of GPER1 mediating es-
trogen response in these immune cells is that by using its specific
agonist it was observed a significant induction in the c-fos expression
levels and some immune-related changes. Furthermore, as it has been
indicated in section 3.2 of this manuscript, a previous paper (Liarte
et al., 2011b) described that these key cells did not express any of
nuclear ERs identified in this fish species, so, the changes observed had
to be only related with GPER1 activation. In the human neutrophils
study, GPER1 staining was detected by using extracellular staining
procedure (with live neutrophils), so, indicating a plasma membrane
localization. Moreover, this result was further confirmed by subcellular
fractionation studies, in which GPER1 was found to be present in the
light membrane (secretory vesicles plus plasma membrane) fraction
(Rodenas et al., 2017a). Therefore, other factors involved in the men-
tioned different effects would be the subcellular localization of GPER1,
and the subsequent signaling pathways activated, the pool of ERs pre-
sent in these cells, and the maturation and activation stage of them,
among others, but it needs to be confirmed. Why GPER1 activation
could lead different effects in immune cells and what is the physiolo-
gical meaning of it, is unknown and need to be explored in more im-
mune cells type and species.
6. Concluding remarks
Although there are controversial data, as occurs in mammals, es-
trogens clearly have the capacity to modulate fish immunity. In this
way, it has been shown that in both fish and mammals estrogens can
modulate all major innate and adaptive immune cells, affecting a wide
range of immune aspects. So, the immunomodulatory role of estrogens
is conserved along evolution, indicating the importance of the inter-
action between estrogens and immune response. Moreover, the fact that
estrogens-mediated effects on immunity can vary depending on several
factors (including concentration used, the time of exposure, immune
cell type and their maturation stage, pool of ERs involved, among
others) has been shown in both mammals and fish, showing that the
immunomodulatory role of estrogen in very complex, as in mammals
(Straub, 2007).
Even though this is a well-established fact, the physiological
meaning of that interaction remains little understood and complex to
determine in some contexts. Nevertheless, it is clear there is a fine-tune
control of immune response by estrogens in several contexts such as
inflammation, autoimmunity, infection, etc. In this way, it has been
demonstrated by multiple facts such as: expression of ERs can be
modulated by immune stimuli, estrogens are able to alter the expression
of immune receptors, some immune genes contain ERE in their pro-
moter regions, ERs are expressed in immune tissues during early de-
velopment stages, and immune cells express steroidogenic enzymes,
among others. Moreover, the differential expression of ERs in different
tissues and cell types balances the estrogens mediated effects.
The physiological importance of the estrogens-mediated effects on
immune response has been shown more clearly in mammals and in
several contexts. It has been described that estrogens are able to control
inflammation and are involved in its resolution (Villa et al., 2015), have
Fig. 1. Simplified scheme of the effects and signaling pathways described for GPER1 activation (by G1, a GPER1 specific agonist) in human neutrophils (left) and
bony fish granulocytes (right). The results demonstrated in the cited papers are indicated with light-grey arrows. For more detail see at the end of section 3.2.
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a neuroprotective effect (Hernandez-Fonseca et al., 2012), and are in
part responsible of the gender differences observed in some immune
disorders (González et al., 2010). In support of this last statement, it is
known that female have lower rates of infection and resultant mortality
than male, but they have an overall increased rate of autoimmune
diseases. In addition, the clinical symptoms of some of these immune
disorders vary in relation to estrogen levels, in both female and male
patients (Cemil et al., 2015; Lin and Huang, 2016). On the other hand,
immune privilege is another context where importance of estrogens-
immunity interaction is highlighted. It is known that some tissue such
as placenta, fetus or reproductive organs have an immune privilege,
being able to tolerate the introduction of antigens without eliciting an
inflammatory immune response. In this context, it has been described in
mammals that T regulatory cells play a critical role in downregulating
immune responses, directing immune response toward tolerance
(Zenclussen, 2006) and that estrogens promote the expansion and fre-
quency of these key cells (Tai et al., 2008). Moreover, these cells are
related with the protective effects of estrogen in autoimmune condi-
tions (Offner and Polanczyk, 2006). In addition, as mentioned above,
GPER1 activation modulates these cells in mammals (Brunsing et al.,
2013), and, even in fish, it has been shown that estrogens regulate
Foxp3, a transcription factor crucial in the activation of T regulatory
cells (Wei et al., 2013). Another crucial context in mammals in which
estrogens-immune interaction take part is during pregnancy, where
high levels of estrogens observed in this period suppress many cytotoxic
and innate immune responses, but stimulate antibody production, neo-
angiogenesis and growth (Straub, 2007). In fish, the relevance of es-
trogen-immunity interactions is also demonstrated by the fact that
seasonal changes of immune system correlate with estrogens levels
(Szwejser et al., 2017c). Moreover, infection or immune privilege are
other fish contexts where estrogen-immunity interactions take im-
portance (Valero et al., 2018).
The study of the interaction between estrogens and immune re-
sponses in fish will help to understand its evolutionary history and
relevance. Nevertheless, in-depth studies to determine the specific
mechanisms involved in these estrogen-mediated effects in both mam-
mals and fish are needed, since most of them are mediated via complex
molecular mechanisms. Moreover, we propose that GPER1 signaling
should be taken into account since this signaling can be involved on the
described estrogen-mediated effects or with new ones yet to be ex-
plored, both in fish and mammals. The study of the presence and role of
GPER1 in fish immune cells may identify this receptor as an evolu-
tionary actor in estrogenic action and will help to determine whether its
signaling pathway is evolutionarily conserved.
Hence, there are a need to perform future studies, for now very
scarce or nonexistent, focused on determining: (i) the presence of
GPER1 in immune cells of other fish species in order to confirm the
evolutionary importance of it; (ii) the relevance and mechanism of
GPER1 activation in key immune processes such as inflammation, in-
fection, haematopoiesis and adaptive immune response, among others;
and (iii) the intrinsic importance of GPER1 in immune cells, by over-
expressing or downregulating its expression in specific immune cell
types. All this information would have implication not only for fish-
related issues, but also for others, such as biomedicine, since GPER1
could be a potential target in some immune disorders in which estro-
gens take part.
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